News Releases

Trial Shows a Single Dose of an Experimental Therapy Reduces Lipoprotein(a), an Important Heart Disease Risk Factor, More than 94% for Nearly a Year

First in-human trial of novel therapy was presented at the American Heart Association’s Scientific Sessions 2023 

International Clinical Trial Finds that Semaglutide Reduced Cardiovascular Events by 20% in Adults with Overweight or Obesity Who Don’t Have Diabetes

SELECT trial presented by Cleveland Clinic physician at the American Heart Association’s Scientific Sessions 2023 

Cleveland Clinic Launches New Quantum Innovation Program for Start-up Companies

Program to foster access to first quantum computer in healthcare, collaboration with researchers 

Cleveland Clinic to Offer Prescription Delivery to Patients’ Homes Using Drones

Program will initially be used for specialty and rush medications starting in 2025 

Cleveland Clinic Abu Dhabi conducts UAE’s first robot-assisted kidney transplants

Cleveland Clinic-Led Trial Finds that Atrial Fibrillation Patients Undergoing TAVR and Watchman™ Procedures Together Have Similar Outcomes to Using Blood Thinners after TAVR

WATCH TAVR trial presented at the Transcatheter Cardiovascular Therapeutics annual conference 

Cleveland Clinic selected by Wellcome Leap for Two Quantum Computing Research Projects